Standout Papers

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance 2017 2026 2020 2023 724
  1. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance (2017)
    Sydney M. Shaffer, Margaret C. Dunagin et al. Nature

Immediate Impact

1 by Nobel laureates 29 from Science/Nature 62 standout
Sub-graph 1 of 19

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
2024 StandoutNature
1 intermediate paper

Works of Katrin Sproesser being referenced

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia
2020
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
2017 StandoutNature

Author Peers

Author Last Decade Papers Cites
Katrin Sproesser 907 444 175 215 15 1.2k
Mercedes Lioni 823 691 132 176 11 1.4k
Anja Sieber 750 221 183 179 19 1.1k
Anne Margriet Heijink 877 406 111 139 13 1.2k
Marco Piva 729 607 212 201 13 1.1k
Alexandra K. Gardino 1142 289 119 101 19 1.5k
Marcus Bosenberg 788 380 186 319 19 1.2k
Andrew L. Ji 925 265 269 236 15 1.2k
Bjoern Papke 981 333 59 118 12 1.2k
Ossia M. Eichhoff 941 486 306 229 17 1.3k
David Twomey 1068 410 194 237 6 1.6k

All Works

Loading papers...

Rankless by CCL
2026